CatalystPit

AMRXAmneal Pharmaceuticals, Inc.

NASDAQ · Pharmaceutical Preparations
Last close $20.14 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$6.43B
RECENT INSIDER TRADES
  • 2026-09-21 · BUCHI J KEVIN (Director) · OTHER
  • 2026-09-14 · BUCHI J KEVIN (Director) · OTHER
  • 2026-09-02 · BOYER ANDREW S (Executive Vice President) · OTHER
  • 2026-08-14 · Kiely John (Director) · SELL
  • 2026-08-14 · Kiely John (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders329
Shares held196,369,152
Value$3.09B
Percent of shares outstanding61.49%
As of quarter end2026-06-30
RECENT NEWS
  • Amneal to report Q3 2026 results on November 3
  • UBS reiterates Amneal Pharmaceuticals stock Buy rating on HRT growth
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Amneal Pharmaceuticals, Inc. (AMRX) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit